Skip to main content
Premium Trial:

Request an Annual Quote

Oh, the Potential

Pharmacogenomics has the potential to improve public health, writes Muin Khoury, the director of the Centers for Disease Control and Prevention's public health genomics office, at the Genomics and Health Impact Blog. About 700,000 emergency department visits each year are due to adverse drug reactions and, Khoury says, genomics, particularly pharmacogenomics could help cut down on those numbers. However, there are only a few pharmcogenomic tests being used in the clinic. "Although considerable information is accumulating on the relationship between genetic variation and drug metabolism and adverse effects, precious little evidence exists for their added value in clinical practice," he writes. Khoury adds, though, that there are initiatives underway to assess the use of pharmacogenomic tests.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.